Celularity Inc. Weighted Average Number of Shares, Restricted Stock
Celularity Inc. (CELU) reported Weighted Average Number of Shares, Restricted Stock of 33.70 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-07-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesRestrictedStock · last filed 2024-07-30
- Celularity Inc. weighted average number of shares, restricted stock for the quarter ending 2022-09-30 was 12.28K shares.
- Celularity Inc. weighted average number of shares, restricted stock for the quarter ending 2022-06-30 was 69.69K shares.
- Celularity Inc. weighted average number of shares, restricted stock for fiscal 2022 was 33.70K shares.
| Period end | Weighted Average Number of Shares, Restricted Stock 3 month | Weighted Average Number of Shares, Restricted Stock 12 month | Weighted Average Number of Shares, Restricted Stock 12 month as first filed |
|---|---|---|---|
| 2022-12-31 | 33.70K shares 10-K · filed 2024-07-30 | 336.97K shares 10-K · filed 2023-03-31 | |
| 2022-09-30 | 12.28K shares 10-Q · filed 2024-01-03 | ||
| 2022-06-30 | 69.69K shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |